Sentence examples for drug safety system from inspiring English sources

Dr. Richard Platt of Harvard Medical School, one of the nation's premier drug safety experts, said a comprehensive drug safety system would be costly.

"When concerns were expressed late last year about drug safety, he responded immediately and constructively by asking the prestigious Institute of Medicine to thoroughly investigate the drug safety system and make recommendations". But others did not give Crawford's performance the same kind reviews.

"The gaping loophole in our drug safety system," says Glenmullen, "is long-term safety.

Two different bipartisan teams in the Senate are pushing for different overhauls of the drug safety system.

"People should turn to Congress and demand a drug safety system that is free from corporate influence--and a distinct center for drug safety". In Graham's eyes, the problem at the FDA is that the same scientists who approve drugs are the ones charged with deciding whether or not they are safe enough to remain on the market when problems crop up.

In 2005 in the aftermath of the Vioxx debacle and withdrawal from the market, Janet Woodcock, Deputy Commissioner of Operations at the FDA, said that the nation's drug safety system had, "pretty much broken down".

The media and professional communicators have an important role, not only as safety partners, but also in scrutinising the performance of drug safety systems.

SPORTSSATURDAY, PAGE D1 F.D.A. Seeking Advice The Food and Drug Administration announced it would hire the government's top scientific review agency to figure out whether its drug-safety system is adequate.

[C2.] Scrutiny for F.D.A. Safety System The Food and Drug Administration announced that it would hire the government's top scientific review agency to figure out whether its drug-safety system is adequate.

A10 SPORTSSATURDAY D1-8 SCIENCE/HEALTH F.D.A. Moves to Analyze Self The Food and Drug Administration announced that it would hire the government's top scientific review agency to figure out whether its drug-safety system is adequate set up an internal appeals process.

36 38 As the accessibility of healthcare information in Japan is strictly regulated by privacy protection, further discussion would be necessary to balance privacy protection with an active drug safety monitoring system.